Jason Stenta brings Optum and CVS Health experience to Walgreens as it struggles with the direction of an ill-fated health ...

CVS risks losing customers and revenue if it splits up its vertically integrated business segments, which includes health ...

Welcome to this week's Chutes & Ladders, our roundup of hirings, firings and retirings throughout the industry. | Welcome to ...

Pharmacy chains are in crisis ...

Talk that CVS Health may break up its businesses would mean unraveling synergies already making the company a lot of money.

Walgreens has named Jason Stenta as senior vice president and chief commercial officer. In this new role, Stenta will lead the company’s commercial growth strategy, driving development and ...

Walgreens has missed on margin expectations for multiple quarters now. Check out why I'm bearish on WBA stock.

Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, ...

The opioid settlement tab for the Deerfield pharmacy chain, already in the realm of $5 billion, just got a little longer.

The market speculates that following the FTC notice, several investors are pushing CVS Health to go for segment breakups.

Walgreens Boots Alliance named ex-Optum executive Jason Stenta as the company's chief commercial officer on Monday. Stenta ...

CVS is the top U.S. pharmacy in terms of prescription drug revenue, holding more than 25% of the market share in 2023, according to Statista data released in March. Walgreens trailed behind with ...